Archives

by in
Entry Author Date Location
Halozyme Gets Key Validation of Enzyme Tech in HyQvia Approval 09/17/14 San Diego
Seattle Genetics Nabs $25M More From AbbVie for Souped Up Antibodies 01/08/14 Seattle
Genentech CMO Hal Barron Joins ‘Building Biotechs to Last’ Dec. 9 11/14/13 San Francisco
Genentech Aims to Set Precedent With FDA OK in Early Breast Cancer 09/11/13 San Francisco
Oncothyreon Nabs $10M, Pays $10M, For Array Biopharma Cancer Drug 05/30/13 Seattle
Merrimack Aims For Penny-Wise Pipeline of Cancer Drugs 05/24/13 Boston
Memorial Sloan-Kettering and Eureka Go After ‘Undruggable’ Targets 03/21/13 New York
Genentech, ImmunoGen Win FDA OK for Souped-Up Breast Cancer Drug 02/22/13 San Francisco
Adimab Grows Up, Looks to Pay Off the VCs In Unusual Way 02/22/13 Boston
Third Rock’s Latest, Jounce, Grabs $47M For Cancer Immunotherapy 02/14/13 Boston
2012: The Year When Genomic Medicine Started Paying Off 12/17/12 National
Zymeworks Hits Antibody Drug Milestone For Merck, Raises $11M 09/06/12 Seattle
Genentech, ImmunoGen Breast Cancer Drug Extends Lives 08/27/12 San Francisco
ImmunoGen Emerges from Genentech’s Shadow With Novel Cancer Drugs 07/12/12 Boston
FDA Clears New Genentech Breast Cancer Drug, in Combo With Herceptin 06/08/12 San Francisco
Genentech Eagerly Awaits FDA Word on 2nd Breast Cancer Drug 06/07/12 San Francisco
Genentech, ImmunoGen ‘Smart Bomb’ for Breast Cancer Blazes New Trail 06/03/12 San Francisco
NanoString Nabs Ex-Seattle Genetics Exec to Lead Diagnostic Push 05/29/12 Seattle
Targeted Cancer Drugs With Punch: The Next Big Class of Antibodies 05/16/12 National
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show 05/14/12 National
Genentech’s Two-Drug Strategy Raises the Bar in Breast Cancer 12/07/11 San Francisco
Genentech Looks to Turn the Page at Breast Cancer Confab 12/01/11 San Francisco
The Cancer Drug Dark Ages Are Coming to an End 10/31/11 National
Genentech, ImmunoGen’s Souped-Up Antibody for Breast Cancer Passes Key Test 09/24/11 San Francisco
KEW, Led by Millennium Co-Founder, Seeks to Bring Big-Time Cancer Care to Community Clinics 04/27/11 Boston
Think Obamacare Will Suffocate New Drug Development With Price Controls? Think Again 03/21/11 National
Where Are Tomorrow’s Blockbuster Biotech Drugs Coming From? You Might be Surprised 03/14/11 National
ImmunoGen CEO Highlights Two New Souped-Up Antibodies Against Cancer 02/25/11 Boston
Adriana Jenkins, Boston Biotech PR Maven, Dies from Breast Cancer at 41 02/10/11 Boston
Genentech Loses Avastin Battle, Fluidigm’s Second Chance at an IPO, Ion Torrent’s Debut, & More Bay Area Life Sciences News 12/17/10 San Francisco
Page 1 of 3 next page »